Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK regulator spells out the safety actions underway:

This article was originally published in Clinica

Executive Summary

A list of actions taken by the UK medical device regulator in response to adverse incident notices during 2002 has been published in the MDA's Adverse Incident Reports 2002 Device Bulletin. There are some 26 groups of responses in all, by the following technical units: biosciences and implants: imaging and acute care; primary and community care; wheeled mobility and searing centre. The reports range from a safety notice outlining best practice in the use of ceramic femoral heads, to developing guidelines on the use of monophasic and biphasic defibrillators, and to issuing safety notices on structural front leg defects of ambulance stretchers. (As of April 1, the MDA has been part of the merged Medicines and Healthcare products Regulatory Agency).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061789

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel